| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,234 | 2,261 | 2,279 | 2,295 | | Cost of Revenue | 1,520 | 1,449 | 1,334 | (4,373) | | | Gross Profit | 714 | 812 | 945 | 6,668 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 826 | 868 | 1,297 | 6,860 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 272 | 265 | 321 | 286 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (384) | (321) | (673) | (478) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5 | 9 | 18 | 427 | | Earnings Before Interest And Taxes | (379) | (312) | (655) | (51) | | Interest Expense | 422 | 437 | 429 | 440 | | Income Before Tax | (801) | (749) | (1,084) | (491) | | Income Tax Expense | (281) | (264) | (415) | (224) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (520) | (485) | (669) | (267) | | | Non-recurring Events | | Discontinued Operations | 48 | (178) | (62) | (6) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (472) | (663) | (731) | (273) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($472) | ($663) | ($731) | ($273) |
|
0.51% Nasdaq 
Income Statement
